Cargando…

Anti-viral properties of antipsychotic medications in the time of COVID-19

Detalles Bibliográficos
Autores principales:	Girgis, Ragy R., Lieberman, Jeffrey A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833567/ https://www.ncbi.nlm.nih.gov/pubmed/33290940 http://dx.doi.org/10.1016/j.psychres.2020.113626

Ejemplares similares

Due to their anti-inflammatory, antioxidant and neurotrophic properties, second-generation antipsychotics are suitable in patients with schizophrenia and COVID-19
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2021)

Long acting injectable antipsychotic medications: Ensuring care continuity during the COVID-19 pandemic restrictions
por: Gannon, Jessica M., et al.
Publicado: (2020)

The role of antipsychotics against COVID-19: A topic for debate
por: Canal-Rivero, M., et al.
Publicado: (2021)

Can antipsychotic use protect from COVID-19?
por: Dratcu, Luiz, et al.
Publicado: (2021)

Study of menstrual irregularities in patients receiving antipsychotic medications
por: Murke, Mukund P., et al.
Publicado: (2011)

Cardiotoxicity of current antipsychotics: Newer antipsychotics or adjunct therapy?
por: Liu, Zheng, et al.
Publicado: (2022)

An overall protective effect of antipsychotic drugs against COVID-19 seems implausible
por: Ruiz de Pellón-Santamaría, Ángel, et al.
Publicado: (2022)

Antipsychotics modified COVID-19 prevalence in hospitalized patients diagnosed with mental illnesses
por: Tendilla-Beltrán, Hiram, et al.
Publicado: (2023)

Medical education in COVID-19 times
por: Gupta, Harish
Publicado: (2023)

Prescriptions of antipsychotics dispensed in long-term care facilities during the COVID-19 pandemic
por: Ali, Mir M., et al.
Publicado: (2022)

Acknowledging the Complexity of Antipsychotic Use in Long-Term Care During the COVID-19 Pandemic
por: Turcotte, Luke Andrew, et al.
Publicado: (2023)

Antipsychotic drug prescription in postgraduate psychiatry training programs in India: Time to reflect
por: Varghese, Sunny T.
Publicado: (2007)

Neuroleptic Malignant Syndrome due to Atypical Antipsychotics in a COVID-19-positive Pregnant Woman
por: Burad, Jyoti, et al.
Publicado: (2021)

Long-acting injectable antipsychotics treatment during COVID-19 pandemic – A new challenge
por: Ifteni, Petru, et al.
Publicado: (2020)

Finding the right time for anti-inflammatory therapy in COVID-19
por: de Simone, Giovanni, et al.
Publicado: (2020)

Antipsychotics and OCD: Boon or Bane?
por: Naguy, Ahmed
Publicado: (2017)

Antiviral and anti-inflammatory properties of ivermectin and its potential use in Covid-19()
por: Portmann-Baracco, Arianna, et al.
Publicado: (2020)

COVID-19: time for a bold new strategy for medical education
por: Watson, Alastair, et al.
Publicado: (2020)

Patient monitoring: the hidden costs of treatment with antipsychotics
por: Nederlof, Mariëtte, et al.
Publicado: (2016)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Comparison of cost-effectiveness of long-acting depot injection antipsychotics and oral antipsychotics in patients with schizophrenia in a rural community in South India
por: Raghavan, Vijaya, et al.
Publicado: (2020)

Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”()
por: Accinelli(), Roberto Alfonso, et al.
Publicado: (2020)

COVID-19 pandemic—testing times for post graduate medical education
por: Agrawal, Siddharth, et al.
Publicado: (2021)

Comments on: COVID-19 pandemic – Testing times for postgraduate medical education
por: Gurnani, Bharat, et al.
Publicado: (2021)

COVID-19 and Civilian Hoarding of Medical Masks: Time for Legal Measures
por: Van den Eynde, Vincent
Publicado: (2020)

Gender differences in the use of atypical antipsychotic medications for ICU delirium
por: Karamchandani, Kunal, et al.
Publicado: (2018)

It is time to consider an anti-inflammatory therapy based on the pathophysiology of COVID-19 infection during the right time window?
por: Ghanei, Mostafa
Publicado: (2021)

Long Acting Injectable Antipsychotics: Ongoing use during the COVID-19 pandemic and successful use of internet-based support in Greece
por: Alevizopoulos, Georgios, et al.
Publicado: (2021)

Clinical perspective on antipsychotic receptor binding affinities
por: Crapanzano, Calogero, et al.
Publicado: (2021)

Comment on: “Clinical Pharmacokinetics of Atypical Antipsychotics: An Update”
por: Periclou, Antonia, et al.
Publicado: (2019)

Considerations on the article «antiviral and anti-inflammatory properties of ivermectin and its potential use in COVID-19»()
por: Hernández-Vásquez, Akram, et al.
Publicado: (2020)

Future career plans of medical students and the COVID‐19 pandemic: Time to recover?
por: Goudarzi, Houman, et al.
Publicado: (2022)

Letter to the Editor: ‘Medical Education in Times of COVID-19: What's New in Neurosurgery?'
por: Lozada-Martínez, Ivan, et al.
Publicado: (2020)

Repetitive and Stereotypic Vocalization in Dementia after Using Antipsychotics
por: Sung, Wonjae, et al.
Publicado: (2021)

Herbs that might be effective for the management of COVID-19: A bioinformatics analysis on anti-tyrosine kinase property
por: Sriwijitalai, Won, et al.
Publicado: (2020)

Time to boost COVID-19 vaccine manufacturing: The need for intellectual property waiver by big pharma
por: Okereke, M., et al.
Publicado: (2021)

Anti-stress Properties of Atypical Antipsychotics
por: Sanson, Alice, et al.
Publicado: (2020)

Viral genome sequencing for Defining Re-infection with COVID-19
por: Ananthan, Velmurugan Anbu
Publicado: (2021)

Into the looking glass: Post-viral syndrome post COVID-19
por: Perrin, Ray, et al.
Publicado: (2020)

Viral shedding in tears of COVID-19 cases presenting as conjunctivitis
por: Goel, Ruchi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nfvarelqki22dnoa1e0bfc86h9